Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05305950 · ClinicalTrials.gov registry record

Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors

A clinical trial of Pediatric Cancer, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
60
Enrollment target
1
Study location

NCT05305950 is a study of Pediatric Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 60 participants, below the 1,489-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05305950, a study of Pediatric Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

This study aims to identify the modifiable facilitators and barriers to occupational and physical therapy care for children during and after cancer treatment that may be contributing to disparities in health outcomes. The investigators will identify these facilitators and barriers by surveying and interviewing healthcare administrators at MD Anderson Cancer center. The investigators will also survey and interview physicians, advanced practice providers, and occupational and physical therapists to obtain their feedback on these issues.

Conditions Studied

Interventions

  • OTHER Patient population

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-12-17
Est. Completion 2026-12-31

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05305950

The ClinicalTrials.gov registry entry for NCT05305950 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,489-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (96% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient population is the first listed.

NCT05305950 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05305950 about?

NCT05305950 is a clinical study titled "Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors". This study aims to identify the modifiable facilitators and barriers to occupational and physical therapy care for children during and after cancer treatment that may be contributing to disparities in health outcomes. The investigators will identify these facilitators and barriers by surveying and i...

What is the current status of trial NCT05305950?

This trial is currently active not recruiting. The enrollment target is 60 participants. The study started on 2021-12-17. Estimated completion is 2026-12-31.

What conditions does trial NCT05305950 study?

This clinical trial studies the following conditions: Pediatric Cancer.

What interventions are being tested in trial NCT05305950?

The interventions under investigation include: Patient population (OTHER).

Who is sponsoring clinical trial NCT05305950?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05305950 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.